about
Hypothetical intertemporal choice and real economic behavior: delay discounting predicts voucher redemptions during contingency-management procedures.Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms.Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients.Adding an Internet-delivered treatment to an efficacious treatment package for opioid dependence.Characterizing methamphetamine withdrawal in recently abstinent methamphetamine users: a pilot field studySertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms.Effect of PTSD diagnosis and contingency management procedures on cocaine use in dually cocaine- and opioid-dependent individuals maintained on LAAM: a retrospective analysisOpen-label pilot study of modafinil for methamphetamine dependence.Sex and opioid maintenance dose influence response to naloxone in opioid-dependent humans: a retrospective analysis.Effects of disulfiram on QTc interval in non-opioid-dependent and methadone-treated cocaine-dependent patients.Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedure.Impact of early childhood trauma on retention and phase advancement in an outpatient buprenorphine treatment program.Quality-adjusted health status in veterans with posttraumatic stress disorder.A comparative study between cod liver oil and liquid lard intake on intraocular pressure on rabbitsStudies on intraocular inflammation produced by intravitreal human interleukins in rabbitsReliability and validity of the substance abuse outcomes module
P50
Q33667420-A19ED8DA-686F-4C1A-A85A-E6A883700936Q33798678-94F052A0-8499-45B0-98E7-C0F521B36D57Q34424620-CB0B12C9-770E-4FAB-878F-01226A5217EFQ34572532-8ABA5D05-7ABF-43B9-A1CB-F5FE5886CD3FQ34713806-4EE21030-51D3-4BCB-997A-D79EF73DCB90Q35612732-408333A9-58F8-4B67-9936-E6DC74942002Q36321679-35FA399E-89CD-452B-88A1-46997381E181Q36722528-04FACE52-D138-441C-BEB5-57A33E34B18DQ36959135-CBAEBA2A-7C88-455E-AE1D-8DC14176964CQ37079673-46120963-2CD7-4933-B27A-CEF18B27C1EDQ37678223-D1434B05-3D89-483B-BF55-B6B27FCA5144Q39388932-A9B0CA1F-986B-46AB-9613-4FB92BF89AA7Q43425410-DE262D19-7EFC-4E2D-8459-A8C3592633B6Q68130192-A2D689C7-AEB8-41FD-AA2B-8FE57A18335CQ72964923-0DDB9455-DE16-474C-8E98-9A7F216B2447Q79225983-FF86E66F-302A-4D30-8290-AEBE28FEA481
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michael J Mancino
@ast
Michael J Mancino
@en
Michael J Mancino
@es
Michael J Mancino
@nl
type
label
Michael J Mancino
@ast
Michael J Mancino
@en
Michael J Mancino
@es
Michael J Mancino
@nl
prefLabel
Michael J Mancino
@ast
Michael J Mancino
@en
Michael J Mancino
@es
Michael J Mancino
@nl
P106
P31
P496
0000-0002-7234-6305